This pre-announcement outlines the upcoming ERDERA Clinical Trial Call 2026 (ECTC), expected to open on 1 July 2026, to support multinational, GCP-compliant Phase I, Phase I/II and Phase II interventional clinical trials in rare diseases.
It summarises priority areas, eligible applicants, eligible interventions (including small molecules, ATMPs and biologics), expected eligible countries and an indicative multi-stage application process, including an information webinar on 6 July 2026 (15:00–17:00 CEST).